Kraematon Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Sell |
913
-141
| -13% | -$110K | 0.67% | 48 |
|
|
2025
Q1 | $870K | Sell |
1,054
-97
| -8% | -$80.1K | 0.89% | 36 |
|
|
2024
Q4 | $889K | Buy |
1,151
+1
| +0.1% | +$772 | 0.88% | 39 |
|
|
2024
Q3 | $1.02M | Buy |
1,150
+155
| +16% | +$137K | 1% | 34 |
|
|
2024
Q2 | $901K | Sell |
995
-24
| -2% | -$21.7K | 0.92% | 37 |
|
|
2024
Q1 | $793K | Buy |
1,019
+40
| +4% | +$31.1K | 0.8% | 42 |
|
|
2023
Q4 | $571K | Buy |
+979
| New | +$571K | 0.63% | 47 |
|
|
2023
Q1 | – | Sell |
-168
| Closed | -$61.5K | – | 174 |
|
|
2022
Q4 | $61.5K | Buy |
+168
| New | +$61.5K | 0.07% | 120 |
|